Related references
Note: Only part of the references are listed.Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature
Sergio Di Nuzzo et al.
DERMATOLOGY (2016)
AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Prevention of HBV reactivation in patients treated with biologic agents
Christos Koutsianas et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
Safety and efficacy of anti-tumor necrosis factors α in patients with psoriasis and chronic hepatitis C
Monica Salvi et al.
WORLD JOURNAL OF CLINICAL CASES (2016)
Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients
Charlie Laohapand et al.
HEPATOLOGY INTERNATIONAL (2015)
EASL Recommendations on Treatment of Hepatitis C 2015
JOURNAL OF HEPATOLOGY (2015)
To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis
Christine S. Ahn et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015-Short version - EDF in cooperation with EADV and IPC
A. Nast et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database
J. Sanz-Bueno et al.
ACTAS DERMO-SIFILIOGRAFICAS (2015)
Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy
Pilar Lopez-Serrano et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents
Joshua Juan et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Outcome of patients with serology suggestive of past hepatitis B virus infection during antitumor necrosis factor therapy for psoriasis
Raquel Navarro et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)
Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis
Mitsuha Hayashi et al.
JOURNAL OF DERMATOLOGY (2014)
From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis
Kiran Motaparthi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
The possibilities and principles of methotrexate treatment of psoriasis - the updated knowledge
Magdalena Czarnecka-Operacz et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2014)
Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease
Stefano Sansone et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Hepatitis B and Hepatitis C Reactivation in the Biologic Era
Lizza Bojito-Marrero et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2014)
HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α)Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis
Fabrizio Cantini et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2014)
Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient
J. Koskinas et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C
H. -Y. Chiu et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting
R. Navarro et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients
R. Laurenti et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Psoriasis treated with ustekinumab in a patient with hepatitis C
Adriana Abuchar et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2013)
Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs
Young Ho Lee et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2013)
Association of hepatitis B with antirheumatic drugs: a case-control study
Yasuo Oshima et al.
MODERN RHEUMATOLOGY (2013)
Chronic hepatitis C virus hepatitis and psoriasis: No longer a contraindication to interferon use in the era of biological agents?
Filippo Bartalesi et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review
Maurizio Pompili et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Hepatitis B and inflammatory bowel disease: Role of antiviral prophylaxis
Pilar Lopez-Serrano et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells
Anna Schurich et al.
PLOS PATHOGENS (2013)
Consensus Guidelines for the Management of Plaque Psoriasis
Sylvia Hsu et al.
ARCHIVES OF DERMATOLOGY (2012)
Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management
Mauro Vigano et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Cyclosporine as Monotherapy for Psoriasis in the Setting of Chronic HCV Infection: A Forgotten Therapeutical Option
Alexandra Maria Giovanna Brunasso et al.
HEPATITIS MONTHLY (2012)
S3-Guidelines on the treatment of psoriasis vulgaris (English version). Update
Alexander Nast et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2012)
Use of anti-tumor necrosis factor-a therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: A case series in Taiwan
Yung-Tsu Cho et al.
JOURNAL OF DERMATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management
Amanda Abramson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis
Ingmar Mederacke et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients
F. Prignano et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Medical comorbidity associated with psoriasis in adults: a population-based study
Y-W. Yang et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C
Michael T. Dill et al.
GASTROENTEROLOGY (2011)
Acitretin revisited in the era of biologics
Marielle Te Booij et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2011)
Safety of anti-tumour necrosis factor-α agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of the literature
C. Fotiadou et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients
Yukitomo Urata et al.
MODERN RHEUMATOLOGY (2011)
Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy Analysis of 257 Cases
Roberto Perez-Alvarez et al.
MEDICINE (2011)
Etanercept in the treatment of psoriasis and psoriatic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients
Martina Zanni et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2011)
Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
D. Vassilopoulos et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Is Etanercept Safe for Treating Plaque Psoriasis in a Patient With Chronic Hepatitis C Virus Infection?
Rishi K. Gandhi et al.
ARCHIVES OF DERMATOLOGY (2010)
Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection
L. Nosotti et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology
A. D. Ormerod et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Etanercept as prophylactic psoriatic therapy before interferon-α and ribavirin treatment for active hepatitis C infection
S. E. Behnam et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2010)
Psoriasis Associated with Hepatitis C but Not with Hepatitis B
Arnon D. Cohen et al.
DERMATOLOGY (2010)
Possible Reactivation of Potential Hepatitis B Virus Occult Infection by Tumor Necrosis Factor-α Blocker in the Treatment of Rheumatic Diseases
Yun Jung Kim et al.
JOURNAL OF RHEUMATOLOGY (2010)
Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: Preliminary data
Eleonora Annichiarico et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: Risk or opportunity?
Vito Di Lernia et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Safety of Tumor Necrosis Factor α Blockers in Hepatitis B Virus Occult Carriers (Hepatitis B Surface Antigen Negative/Anti-Hepatitis B Core Antigen Positive) With Rheumatic Diseases
R. Caporali et al.
ARTHRITIS CARE & RESEARCH (2010)
Efficacy and safety of etanercept in patients with psoriasis and hepatitis C
Filipa Ventura et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2010)
British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009
C. H. Smith et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Treatment of erythrodermic psoriasis in HCV plus patient with adalimumab
Antonio Giovanni Richetta et al.
DERMATOLOGIC THERAPY (2009)
Switch from etanercept to efalizumab in a psoriatic patient with HCV infection: a case report
F. Prignano et al.
DERMATOLOGIC THERAPY (2009)
Reactivation of Hepatitis B
Jay H. Hoofnagle
HEPATOLOGY (2009)
Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection
Alberto Conde-Taboada et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Treatment of psoriasis in patients with hepatitis C: From the Medical Board of the National Psoriasis Foundation
Amylynne J. Frankel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference
Robert E. Kalb et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients
Caroline Charpin et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases
I. Cavazzana et al.
AUTOIMMUNITY REVIEWS (2008)
Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection
Nicoletta Cassano et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2008)
Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection
A. J. Alcaide et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Effective control of psoriasis by etanercept in a patient with HCV-related diseases
Domenico Piccolo et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2008)
Ciclosporin treatment of psoriasis in a patient with chronic hepatitis C
S. Imafuku et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Prophylaxis and treatment of hepatitis B in immunocompromised patients
A. Marzano et al.
DIGESTIVE AND LIVER DISEASE (2007)
Inhibition of TNFα does not induce viral reactivation in patients with chronic hepatitis C infection:: two cases
S. Aslanidis et al.
CLINICAL RHEUMATOLOGY (2007)
Treatment of psoriasis with adalimumab
G. Pitarch et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2007)
Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies
L. H. Calabrese et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection
C Rokhsar et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Etanercept therapy in two patients with psoriasis and concomitant hepatitis C
Clara De Simone et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Current severe psoriasis and the Rule of Tens
AY Finlay
BRITISH JOURNAL OF DERMATOLOGY (2005)
Methotrexate for induction of remission in refractory Crohn's disease
AAF Alfadhli et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Restoration of immunity and reactivation of hepatitis B virus after immunosuppressive therapy in a patient with severe aplastic anaemia
MS Dai et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases
MA Magliocco et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
K Watashi et al.
HEPATOLOGY (2003)
Interleukin-12 in the treatment of chronic hepatitis B and C
S Zeuzem et al.
ANTIVIRAL RESEARCH (2001)
Psoriasis - epidemiology and clinical spectrum
E Christophers
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2001)
Share Paper
